Market Closed -
Nyse
01:30:02 18/06/2024 am IST
|
5-day change
|
1st Jan Change
|
25.17
USD
|
0.00%
|
|
-1.02%
|
+12.47%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,971
|
2,123
|
2,198
|
1,795
|
2,666
|
3,639
|
-
|
-
|
Enterprise Value (EV)
1 |
2,506
|
2,650
|
2,852
|
1,795
|
2,967
|
4,336
|
4,479
|
4,619
|
P/E ratio
|
42.1
x
|
26.1
x
|
30.9
x
|
-232
x
|
44.8
x
|
24.9
x
|
22.5
x
|
23.3
x
|
Yield
|
4.36%
|
4.51%
|
4.64%
|
5.92%
|
5%
|
4.62%
|
4.8%
|
5.11%
|
Capitalization / Revenue
|
12.1
x
|
11.9
x
|
11.4
x
|
9.15
x
|
12.2
x
|
15
x
|
13.7
x
|
13.7
x
|
EV / Revenue
|
15.3
x
|
14.9
x
|
14.8
x
|
9.15
x
|
13.6
x
|
17.8
x
|
16.9
x
|
17.4
x
|
EV / EBITDA
|
15.7
x
|
16.7
x
|
16.4
x
|
9.95
x
|
15.2
x
|
18.5
x
|
16.8
x
|
16.2
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
2.4
x
|
2.17
x
|
2.06
x
|
2.4
x
|
2.32
x
|
2.25
x
|
Nbr of stocks (in thousands)
|
95,557
|
95,736
|
96,297
|
96,605
|
1,19,112
|
1,44,564
|
-
|
-
|
Reference price
2 |
20.63
|
22.18
|
22.83
|
18.58
|
22.38
|
25.17
|
25.17
|
25.17
|
Announcement Date
|
20/02/20
|
10/02/21
|
16/02/22
|
09/02/23
|
08/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
163.4
|
178.3
|
192.4
|
196.1
|
217.8
|
243.2
|
264.9
|
265.8
|
EBITDA
1 |
159.5
|
158.6
|
174.1
|
180.3
|
195.6
|
234.9
|
266.7
|
284.7
|
EBIT
1 |
-
|
104.6
|
106.6
|
116.3
|
135.2
|
150
|
165
|
176.7
|
Operating Margin
|
-
|
58.64%
|
55.4%
|
59.29%
|
62.07%
|
61.68%
|
62.28%
|
66.47%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
71.98
|
-
|
-
|
113.8
|
120.1
|
124.1
|
Net income
1 |
46.36
|
80.87
|
71.98
|
-7.506
|
53.74
|
139.3
|
164.9
|
176.5
|
Net margin
|
28.37%
|
45.35%
|
37.42%
|
-3.83%
|
24.68%
|
57.3%
|
62.24%
|
66.41%
|
EPS
2 |
0.4900
|
0.8500
|
0.7400
|
-0.0800
|
0.5000
|
1.010
|
1.120
|
1.082
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.9000
|
1.000
|
1.060
|
1.100
|
1.120
|
1.162
|
1.208
|
1.285
|
Announcement Date
|
20/02/20
|
10/02/21
|
16/02/22
|
09/02/23
|
08/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
49.74
|
46.48
|
47.55
|
50.29
|
51.81
|
50.61
|
51.55
|
55.88
|
59.73
|
63.07
|
63
|
64.63
|
66.12
|
67.68
|
69.23
|
EBITDA
1 |
44.95
|
43.12
|
43.26
|
45.84
|
48.1
|
45.77
|
46.54
|
49.9
|
53.42
|
56.86
|
58.25
|
59.82
|
61.29
|
62.67
|
66.01
|
EBIT
1 |
23.84
|
25.82
|
28.67
|
28.38
|
33.41
|
31.46
|
-
|
-
|
37.72
|
40.32
|
37.61
|
38.07
|
38.26
|
40.26
|
41.58
|
Operating Margin
|
47.92%
|
55.55%
|
60.3%
|
56.43%
|
64.48%
|
62.17%
|
-
|
-
|
63.15%
|
63.93%
|
59.7%
|
58.9%
|
57.86%
|
59.48%
|
60.06%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
28.75
|
28.88
|
28.76
|
28.68
|
29.29
|
30.64
|
Net income
1 |
18.26
|
-43.26
|
20.67
|
0.709
|
14.38
|
19.23
|
-0.484
|
8.696
|
26.3
|
28.75
|
35.79
|
36.91
|
38.1
|
38.91
|
41.28
|
Net margin
|
36.72%
|
-93.09%
|
43.47%
|
1.41%
|
27.76%
|
37.99%
|
-0.94%
|
15.56%
|
44.02%
|
45.58%
|
56.82%
|
57.11%
|
57.63%
|
57.49%
|
59.62%
|
EPS
2 |
0.1800
|
-0.4500
|
0.2100
|
0.0100
|
0.1500
|
0.1900
|
-0.0100
|
0.0800
|
0.2200
|
0.2200
|
0.2580
|
0.2645
|
0.2676
|
0.2700
|
0.2776
|
Dividend per Share
2 |
0.2650
|
0.2750
|
0.2750
|
0.2750
|
0.2750
|
0.2800
|
0.2800
|
0.2800
|
0.2800
|
-
|
0.2900
|
0.2900
|
0.2933
|
0.3017
|
0.3017
|
Announcement Date
|
16/02/22
|
05/05/22
|
04/08/22
|
08/11/22
|
09/02/23
|
10/05/23
|
03/08/23
|
09/11/23
|
08/02/24
|
02/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
534
|
527
|
654
|
-
|
301
|
697
|
840
|
980
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.35
x
|
3.32
x
|
3.754
x
|
-
|
1.539
x
|
2.969
x
|
3.149
x
|
3.442
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
4.74%
|
9.15%
|
9.25%
|
9.15%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
5.31%
|
5.62%
|
5.28%
|
5.02%
|
Assets
1 |
-
|
-
|
-
|
-
|
1,012
|
2,478
|
3,123
|
3,517
|
Book Value Per Share
2 |
-
|
-
|
9.510
|
8.580
|
10.90
|
10.50
|
10.80
|
11.20
|
Cash Flow per Share
2 |
-
|
-
|
1.630
|
1.460
|
1.460
|
1.610
|
1.710
|
1.780
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
10/02/21
|
16/02/22
|
09/02/23
|
08/02/24
|
-
|
-
|
-
|
Last Close Price
25.17
USD Average target price
26.67
USD Spread / Average Target +5.95% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.47% | 363.87Cr | | +15.10% | 6.21TCr | | +0.32% | 2.02TCr | | -2.22% | 1.36TCr | | +5.94% | 802.58Cr | | -4.24% | 611.35Cr | | +0.28% | 331.27Cr | | +19.87% | 290.73Cr | | -10.45% | 289.86Cr | | -2.04% | 288.65Cr |
Healthcare REITs
|